Astera Labs (ALAB) Cash & Equivalents (2023 - 2026)

Astera Labs (ALAB) has 4 years of Cash & Equivalents data on file, last reported at $148.3 million in Q1 2026.

• Quarterly Cash & Equivalents rose 71.56% year-over-year to $148.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $148.3 million (up 71.56% YoY) and the FY2025 annual result came in at $167.6 million, up 110.7% from the prior year.
• Cash & Equivalents eased to $148.3 million in Q1 2026, from $167.6 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $696.1 million in Q1 2024 to a low of $45.1 million in Q4 2023.
• A 4-year average of $207.3 million and a median of $144.3 million in 2025 frame the typical range for Cash & Equivalents.
• The widest YoY moves for Cash & Equivalents: up 110.7% in 2025, down 87.58% in 2025.
• Tracing ALAB's Cash & Equivalents over 4 years: stood at $45.1 million in 2023, then jumped by 76.4% to $79.6 million in 2024, then surged by 110.7% to $167.6 million in 2025, then fell by 11.53% to $148.3 million in 2026.
• The last three Cash & Equivalents figures came in at $148.3 million (Q1 2026), $167.6 million (Q4 2025), and $140.4 million (Q3 2025), per Business Quant data.